[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355923-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355923-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-profiling-of-breast-cancer-pleural-effusions-using-cytology-specimens-impact-of-sample-source-and-cytological-features-on-next-generation-sequencing-performance","Molecular profiling of breast cancer pleural effusions using cytology specimens - Impact of sample source and cytological features on next-generation sequencing performance","","Malignant effusions in breast cancer provide a minimally invasive material for molecular profiling, yet effusion-derived cytology specimens differ in DNA concentration and turnaround time. This study evaluates mutational profiles and clinical correlates using next-generation sequencing across 22 breast adenocarcinoma pleural effusions identified from 2400 malignant effusion cases. Both cell blocks and post-ThinPrep PreservCyt supernatant are assessed for tumor cellularity, fluid volume, DNA yield, and mutation detection performance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-profiling-of-breast-cancer-pleural-effusions-using-cytology-specimens-impact-of-sample-source-and-cytological-features-on-next-generation-sequencing-performance/355923/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-profiling-of-breast-cancer-pleural-effusions-using-cytology-specimens-impact-of-sample-source-and-cytological-features-on-next-generation-sequencing-performance/355923.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What effusion-derived specimen types were compared for next-generation sequencing (NGS) performance?","Question",{"text":63,"@type":64},"The study evaluated cell blocks (CB) and post-ThinPrep PreservCyt (PTPC) supernatant for tumor cellularity, DNA concentration, turnaround time, and mutation detection.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did tumor cellularity and fluid volume influence successful NGS?",{"text":68,"@type":64},"NGS success was achieved in all 22 cases, with successful sequencing reported in low-volume samples that had high tumor cellularity.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cytology-related and molecular findings differed by hormone receptor status?",{"text":72,"@type":64},"Higher tumor cellularity was associated with bloody effusions, and TP53 mutations were more common in estrogen receptor-negative and triple-negative effusions. ER-negative disease also showed shorter time from diagnosis to effusion development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355923,1790612692,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","DOI: 10. 1002/cncy.70125  \nORIGINAL ARTICLE  \nMolecular profiling of breast cancer pleural effusions using cytology specimens: Impact of sample source and cytological features on next-generation sequencing performance  \nHarpreet Virk MD 1 | Claire Michael MD 1 | Keri Ann Pfeil MS2 | Navid Sadri MD 1 | Philip Bomeisl DO1 | Aparna Harbhajanka MD 1   \n1Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA  \n2Clinical Research Biostatistician, UH Center for Clinical Research, Cleveland, Ohio, USA  \nCorrespondence  \nAparna Harbhajanka.  \n[Email:](Email: Aparna.Harbhajanka@uhhospitals.org)[ Aparna.Harbhajanka@uhhospitals.org](Email: Aparna.Harbhajanka@uhhospitals.org)  \nABSTRACT  \nBackground: Malignant effusions in breast cancer are a minimally invasive source for molecular profiling. Effusion-derived cytology specimens, cell blocks (CB) and post-ThinPrep PreservCyt (PTPC) supernatant, are reliable sources for molecular testing but differ in DNA concentration and turnaround time (TAT). This study evaluates mutational profiles, cytology characteristics, and clinical correlates to assess the utility of effusion-based molecular testing in breast cancer.  \nMethods: The authors screened 2400 malignant effusion cases, identifying 22 cases of breast adenocarcinoma effusions that underwent next-generation sequencing (NGS). Both CB and PTPC supernatant were evaluated for tumor cellularity, fluid volume, DNA concentration, TAT, and mutation detection. Associations with clinicopathological features and outcomes were explored.  \nResults: NGS was successful in all 22 cases (mean volume, 426.5 mL; mean tumor cellularity, 50%). Successful sequencing was achieved in low volume samples with high tumor cellularity. Higher tumor cellularity (>50%) was associated with bloody effusions (p = .016). PTPC supernatant yielded 5-fold higher DNA (mean 177.4 ng/µL vs. 33.8 ng/µL) and shorter TAT by 9 days (15 vs. 24 days). TP53 mutations were more common in estrogen receptor (ER)-negative and triple-negative breast effusions (p = .025). Mutations in PIK3CA, TP53, CCND1, and AKT were reliably detected. Time from diagnosis to effusion development was significantly shorter in ER negative disease (p = .001)  \nConclusions: Effusion cytology using PTPC supernatant, support successful NGSeven in low-volume samples. ER-negative and triple-negative effusions demonstrate more aggressive molecular features including enrichment of TP53 mutations and earlier effusion development. Effusion-based molecular testing yields clinically relevant genomic information in advanced breast cancer.  \nKEYWORDS  \nbreast cancer, NGS on effusions, post-ThinPrep PreservCyt fluid, tumor cellularity  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2026 The Author(s). Cancer Cytopathology published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nCancer Cytopathol. 2026;e70125. wi[leyonlinelibrary.com/journal/cncy](leyonlinelibrary.com/journal/cncy- 1 of 9)[-](leyonlinelibrary.com/journal/cncy- 1 of 9)[ 1 of 9](leyonlinelibrary.com/journal/cncy- 1 of 9)  \n[https://doi.org/10.1002/cncy.70125](https://doi.org/10.1002/cncy.70125)  \nINTRODUCTION  \nBreast cancer is biologically heterogeneous, therefore, molecular characterization is central to prognostication and therapeutic decision-making.1 Although tissue biopsies remain the gold standard for molecular testing, access to adequate tissues can be limited inpatients with advanced or metastatic disease, particularly when repeat sampling is required. Malignant serous effusions, most commonly pleural effusions, frequently occur in advanced breast cancer and represent an underused, accessible source of tumor material for ancillary ","cbCaiaR7OwUdK4Bo","https://ap.wps.com/l/cbCaiaR7OwUdK4Bo","pdf",706540,"English","# Introduction\n## Materials and Methods\n## Results\n## Discussion","[{\"question\":\"What effusion-derived specimen types were compared for next-generation sequencing (NGS) performance?\",\"answer\":\"The study evaluated cell blocks (CB) and post-ThinPrep PreservCyt (PTPC) supernatant for tumor cellularity, DNA concentration, turnaround time, and mutation detection.\"},{\"question\":\"How did tumor cellularity and fluid volume influence successful NGS?\",\"answer\":\"NGS success was achieved in all 22 cases, with successful sequencing reported in low-volume samples that had high tumor cellularity.\"},{\"question\":\"Which cytology-related and molecular findings differed by hormone receptor status?\",\"answer\":\"Higher tumor cellularity was associated with bloody effusions, and TP53 mutations were more common in estrogen receptor-negative and triple-negative effusions. ER-negative disease also showed shorter time from diagnosis to effusion development.\"}]","Molecular profiling of breast cancer pleural effusions using cytology specimens - Impact of sample source and cytological features on next-generation sequencing performance | PDF",1790121777,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d46bb3f09016bb68f1e9b53d39f87c2.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4a91df6ca633f801885df7f91d6d5ab.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2dd74641b6973b30a8505a7f8159c16.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03b95f905fb333a99159cfa947671a9b.webp",980,1287]